Advisory Research’s Recursion Pharmaceuticals RXRX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-135,683	Closed	-$1.01M	–	475
2023 Q2	$1.01M	Buy	+135,683	New	+$1.01M	0.13%	200
2022 Q4	–	Sell	-96,803	Closed	-$1.03M	–	399
2022 Q3	$1.03M	Buy	96,803 +34,999	+57%	+$372K	0.1%	163
2022 Q2	$503K	Buy	+61,804	New	+$503K	0.05%	229